Clinical Trial Update: Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda [Phase 4]

View source ↗

Summary

This update reports that a Phase 4 trial evaluating topical cyclosporine for Vernal keratoconjunctivitis in Rwanda has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vernal Keratoconjunctivitis

Drugs mentioned

• Cyclosporine ophthalmic solution (cyclosporine)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Vernal Keratoconjunctivitis | Phase 4 | Status: COMPLETED